Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys

Psychopharmacology

Volumn 146, Issue 1, 1999, Pages 49-59

  Nicholson, Katherine L ^a   Hayes, Belinda A ^b   Balster, Robert L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Critical Care and Addict Drug Prod ^*  (United States)

Author keywords

Dextromethorphan; Dextrorphan; Drug discrimination; Monkey; Phencyclidine; Rat; Self administration

Indexed keywords

DEXTROMETHORPHAN; DEXTRORPHAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ACTIVITY; DRUG DISCRIMINATION; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RHESUS MONKEY;

ANIMALS; ANTITUSSIVE AGENTS; DEXTROMETHORPHAN; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; MACACA MULATTA; MALE; PHENCYCLIDINE; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 0032822457     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051087     Document Type: Article

References (68)

1. Aram JA, Martin D, Tomczyk M, Zeman S, Millar J, Pohler G, Lodge D (1989) Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J Pharmacol Exp Ther 248:320-328
2. Aylward M, Maddock J, Davies DE, Protheroe DA, Leideman T (1984) Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. Eur J Respir Dis 65:283-291
3. Balster RL (1991a) Discriminative stimulus properties of phencyclidine and other NMDA antagonists. In: Glennon RA, Järbe TUC, Frankenheim J (eds) Drug discrimination: applications to drug abuse research (National Institute on Drug Abuse Research Monograph Series 116, DHHS Publication No.(ADXM) 92-1878). U.S. Government Printing Office, Washington, DC, pp 163-180
4. Balster RL (1991b) Drug abuse potential evaluation in animals. Br J Addict 86:549-1558
5. Balster RL, Willetts J (1996) Phencyclidine: a drug of abuse and a tool for neuroscience research. In: Schuster CR, Kuhar MJ (eds) Pharmacological aspects of drug dependence: towards an integrated neurobehavioral approach. (Handbook of Experimental Pharmacology, vol 118). Springer, Berlin Heidelberg New York, pp 233-262
6. Balster RL, Nicholson KL, Sanger DJ (1994) Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug Alcohol Depend 35:211-216
7. Balster RL, Mansbach RS, Shelton, KL Nicholson KL, Grech DM, Wiley JL, Li H, Weber E (1995) Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists. Behav Pharmacol 6:577-589
8. Beardsley PM, Balster RL (1993) The effects of delay of reinforcement and dose on the self-administration of cocaine and procaine in rhesus monkeys. Drug Alcohol Depend 34:37-43
9. Beardsley PM, Hayes BA, Balster RL (1990) The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J Pharmacol Exp Ther 252:953-959
10. Bem JL, Peck R (1992) Dextromethorphan: an overview of safety issues. Drug Saf 7:190-199
11. Brady KT, Balster RL, May EL (1982a) Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats. Science 215:178-180
12. Brady KT, Woolverton WL, Balster RL (1982b) Discriminative stimulus and reinforcing properties of etoxadrol and dexoxadrol in monkeys. J Pharmacol Exp Ther 220:56-62
13. Chapman AG, Meldrum BS (1989) Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice. Eur J Pharmacol 166:201-211
14. Church J, Lodge D, Berry SC (1985) Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur J Pharmacol 111:185-190
15. 2+ concentration. Neurosci Lett 124:232-234
16. Church J, Sawyer D, McLarnon JG (1994) Interactions of dextromethorphan with the N-methyl-D-aspartate receptor-channel complex: single channel recordings. Brain Res 666:189-194
17. Coughenour LL, Brahce LJ, Courtland GG, Johnson G, Malone T, Probert AW, Marcoux FW (1988) PCP receptor binding affinity predicts potency in inhibiting glutamate induced calcium accumulation in neuronal cell cultures. In: Cavalheiro EA, Lehmann J, Turski L (eds) Frontiers in excitatory amino acid research. Liss, New York, pp 563-566
18. Elliott K, Hynansky A, Inturrisi CE (1994) Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 59:361-368
19. Ferkany JW, Borosky SA, Clissold DB, Pontecorvo MJ (1988) Dextromethorphan inhibits NMDA-induced convulsions. Eur J Pharmacol 151:151-154
20. Fleming PM (1986) Dependence on dextromethorphan hydrobromide. BMJ 293:597
21. France CP, Snyder AM, Woods JH (1989) Analgesic effects of phencyclidine-like drugs in rhesus monkeys. J Pharmacol Exp Ther 250:197-201
22. France CP, Moerschbaecher JM, Woods JH (1991) MK-801 and related compounds in monkeys: discriminative stimulus effects on a conditional discrimination. J Pharmacol Exp Ther 257:727-733
23. 3H] dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Mol Pharmacol 41:134-146
24. Goldberg M, Pham P, Choi D (1987) Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture. Neurosci Lett 80:11-15
25. Grant KA, Colombo G, Grant J, Rogawski MA (1996) Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists. Neuropharmacology 35: 1709-1719
26. Herling S, Solomon RE, Woods JH (1981) Ketamine-like discriminative effects of some opioids in rhesus monkeys. Pharmacologist 23:152
27. Holtzman SG (1980) Phencyclidine-like discriminative effects of opioids in the rat. J Pharmacol Exp Ther 214:614-619
28. Holtzman SG (1982) Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey. Psychopharmacology 77:295-300
29. Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MA, Cowan A (eds) Testing and evaluation of drugs of abuse. Wiley-Liss, New York, pp 193-210
30. Holtzman SG (1994) Discriminative stimulus effects of dextromethorphan in the rat. Psychopharmacology 116:249-254
31. Ikjaer S, Dirks J, Brennum J, Wernberg M, Dahl JB (1997) Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans. Br J Anaesth 79:600-605
32. Isbell H, Fraser HF (1953) Actions and addiction liabilities of Dromoran derivatives in man. J Pharmacol Exp Ther 107:524-530
33. Jackson A, Sanger DJ (1988) Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors? Psychopharmacology 96:87-92
34. Jacqz-Aigrain E, Gueguen M, Zanger UM, Robieux I, Alvarez F (1991) Cytochrome P450IID subfamily in non-human primates. Biochem Pharmacol 41:1657-1663
35. Johanson CE, Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull Narc 3:43-54
36. Klein M, Musacchio JM (1989) High affinity dextromethorphan binding sites in guinea pig brain. Effects of sigma ligands and other agents. J Pharmacol Exp Ther 251:207-215
37. Leander JD, Lawson RR, Ornstein PL, Zimmerman DM (1988) N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs. Brain Res 448:115-120
38. Lennard MS (1990) Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal. Pharmacol Toxicol 67:273-283
39. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ, Frenk H (1993) Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral neuropathy. Brain Res 605:164-168
40. Meisch RA (1987) Factors controlling drug reinforced behavior. Pharmacol Biochem Behav 27:367-371
41. Monaghan DT, Larsen H (1997) NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology. J Pharmacol Exp Ther 280:614-620
42. Morse WH (1976) Introduction: the control of behavior by consequent drug injections. Pharmacol Rev 27:301-305
43. Murray TF, Leid ME (1984) Interaction of dextrorotary opioids with phencyclidine recognition sites in rat brain membranes. Life Sci 34:1899-1911
44. Nankai M, Klarica M, Fage D, Carter C (1998) The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters. Prog Neuropsychopharmacol Biol Psychiatry 22:35-64
45. Netzer R, Pfimlin P, Trube G (1993) Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur J Pharmacol 238:209-216
46. Nicholson KL (1998) The behavioral pharmacology of novel N-methyl-D-aspartate receptor channel blockers (doctoral dissertation). Virginia Commonwealth University, Richmond, Virginia
47. Nicholson KL, Jones HE, Balster RL (1998) Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine. Behav Pharmacol 9:231-243
48. Otton SV, Tyndale RF, Wu D, Inaba T, Kalow W, Sellers EM (1992) Catalytic and immunologic similarities between monkey and human liver cytochrome P450Db1 (human cytochrome p-450 2D6). Drug Metab Disposit 20:1-5
49. Otton SV, Wu D, Tyndale RF, Woods JH, France CP, Balster RL, Nicholson KL, Sellers EM (1996) Disposition of dextromethorphan (DEX) and hydrocodone in the rhesus monkey: role of CYP2D. In: Harris L (ed) Problems of drug dependence 1994. (NIDA Research Monograph Series, vol 153) p 416
50. Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantane). Neuropharmacology 32:1337-1350
51. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34:1239-1258
52. Porter RHP, Greenamyre JT (1995) Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J Neurochem 64:614-623
53. Ramachander G, Williams FD, Emele JF (1977) Determination of dextrorphan in plasma and evaluation of bioavailability of dextromethorphan hydrobromide in humans. J Pharmacol Sci 66:1047-1048
54. Rogawski MA (1992) The NMDA receptor, NMDA antagonism and epilepsy therapy: a status report. Drugs 44:279-292
55. Schmitt B, Netzer R, Fanconi S, Baumann P, Boltshauser E (1994) Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients. J Neurol Neurosurg Psychiatry 57:333-339
56. Slifer BL, Balster RL (1983) Reinforcing properties of stereoisomers of the putative sigma agonists n-allylnormetazocine and cyclazocine in rhesus monkeys. J Pharmacol Exp Ther 225: 522-528
57. Steinberg GK, Kunis D, DeLaPaz R, Poljak A (1993) Neuroprotection following focal cerebral ischemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile. Neurol Res 15:174-180
58. Stretch R, Gerber GJ, Lane E (1976) Cocaine self-injection behavior under schedules of delayed reinforcement in monkeys. Can J Physiol Pharmacol 54:632-638
59. Walker FO, Hunt VP (1989) An open label trial of dextromethorphan in Huntington's disease. Clin Neuropharmacol 12:322-330
60. Walker J, Yatham LN (1993) Benylin (dextromethorphan) abuse and mania. BMJ 306:896
61. Willetts J, Balster RL (1988a) The discriminative stimulus effects of N-methyl-D-aspartate antagonists in phencyclidine-trained rats. Neuropharmacology 27:1249-1256
62. Willetts J, Balster RL (1988b) Phencyclidine-like discriminative stimulus properties of MK-801 in rats. Eur J Pharmacol 146:167-169
63. Willetts J, Balster RL, Leander JD (1990) The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423-428
64. Winger G, Stitzer ML, Woods JH (1975) Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. J Pharmacol Exp Ther 195:505-514
65. Wolfe TR, Caravati EM (1995) Massive dextromethorphan ingestion and abuse. Am J Emerg Med 13:174-176
66. Wu D, Otton SV, Kalow W, Sellers EM (1995) Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat. J Pharmacol Exp Ther 274:1431-1437
67. Young AM, Herling S (1986) Drugs as reinforcers: studies in laboratory animals. In: Goldberg SR, Stolerman IP (eds) Behavioral analysis of drug dependence. Academic Press, Orlando, pp 9-67
68. Young AM, Woods JH (1981) Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J Pharmacol Exp Ther 218: 720-727